The human ␣1,3-fucosyltransferase, Fuc-TVII, a key enzyme in the biosynthesis of selectin ligands, was expressed as a soluble protein-A chimeric form in a human B cell lymphoma cell line, Namalwa KJM-1, and purified using IgG-Sepharose. The enzymatic properties of recombinant soluble Fuc-TVII were then examined. Its enzyme activity was highest at pH 7.5, and the presence of 25 mM Mn 2؉ was required for full activity. Fuc-TVII exhibits an acceptor specificity restricted to ␣2,3-sialylated type 2 oligosaccharides, and the apparent K m values for ␣2,3-sialyl lacto-N-neotetraose and GDP-fucose were 3.08 mM and 16.4 M, respectively. The inhibitory effects of various nucleotides on the activity of Fuc-TVII reflected its donor specificity for the nucleotide portion of GDP. Fuc-TVII was demonstrated to be useful for the synthesis of a sialyl Lewis x hexasaccharide from lacto-N-neotetraose in combination with an ␣2,3-sialyltransferase, ST3Gal IV. Polyethylene glycols enhanced the thermal stability of Fuc-TVII, leading to increased formation of the reaction product.Cell surface glycoproteins and glycolipids containing ␣1,3-fucosylated lactosaminoglycans play important roles in cell-cell interaction and cell migration in connection with physiological and pathological processes such as embryogenesis, cancer metastasis, lymphocyte trafficking, and immune responses (1, 2). In particular, the sialyl Lewis x (sLe x ; NeuAc␣2-3Gal1-4(Fuc␣1-3)GlcNAc) oligosaccharide structure and related structures have evoked considerable interest because they were demonstrated to serve as ligands for the three known selectins (E-, P-, and L-selectins), which are cell adhesion molecules involved in the recruitment of leukocytes to lymphoid tissues and the sites of inflammation (2-6).The biosynthesis of ␣1,3-fucosylated lactosaminoglycans requires the actions of several glycosyltransferases. Among them, an ␣1,3-fucosyltransferase (Fuc-T) is considered to be the key enzyme, which catalyzes the transfer of fucose from GDPfucose to N-acetylglucosamine via an ␣1,3-linkage. The expression-cloning approach led to the cloning of the first human ␣1,3-Fuc-T, Fuc-TIII (7). Subsequently, low stringency hybridization-cloning and expression-cloning approaches revealed the cDNAs for three additional members, Fuc-TIV, Fuc-TV, and Fuc-TVI (8 -13). Detailed analyses have shown that Fuc-TIII, Fuc-TIV, and Fuc-TVI correspond to Lewis-type, myeloid-type, and plasma-type enzymes, respectively (7-10, 14). Biochemical analyses involving enzyme preparations extracted from human tissues and/or the respective recombinant proteins revealed their acceptor specificities, pH optima, kinetic properties, cation requirements, and N-ethylmaleimide (NEM) 1 sensitivities (15-20).We (21) and Natsuka et al. (22) previously cloned a novel human ␣1,3-Fuc-T, Fuc-TVII, expressed in myeloid lineage cells that had never been characterized biochemically. We presented evidence of its involvement in the biosynthesis of an E-selectin ligand. Recent studies have also demonstrated its involveme...